HighVista Strategies »

Kanzhun shares owned by HighVista Strategies

Quarter-by-quarter ownership of Kanzhun (BZ) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Kanzhun

Tip: Access up to 7 years of quarterly data

All positions including Kanzhun held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kanzhun by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2025-09-30 $442k 19k 23.36
2025-06-30 $560k 31k 17.84
2025-03-31 $228k 12k 19.17

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Abivax Sa Sponsored Ads (ABVX)
Merus N V (MRUS)
Miragen Therapeutics (VRDN)
Revolution Medicines (RVMD)
Protagonist Therapeutics (PTGX)
Nuvalent Inc-a (NUVL)
Mineralys Therapeutics (MLYS)
Arcellx Common Stock (ACLX)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Insmed Com Par $.01 (INSM)
Cidara Therapeutics Com New (CDTX)
Cogent Biosciences (COGT)
Structure Therapeutics Sponsored Ads (GPCR)

View all positions for HighVista Strategies

Top funds holding Kanzhun

Capital World Investors
Schroder Investment Management Group
Krane Funds Advisors
BlackRock
Vanguard Group
Morgan Stanley
CoreView Capital Management
Baillie Gifford & Co
Acadian Asset Management
Capital Research and Management Company - Division 3
Jpmorgan Chase & Co
State Street Corporation
Ward Ferry Management
Serenity Capital Management Pte
Artisan Partners Limited Partnership

View all funds holding Kanzhun